Neuroleptic malignant syndrome.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002389:Catatonia / Q000139:chemically induced*; D006801:Humans; D009127:Muscle Rigidity / Q000139:chemically induced*; D013577:Syndrome
D014150:Antipsychotic Agents